Emerson Exchange 365

Activity

BioPhorum MES of the Future

Jim Cahill

We’ve highlighted the work of Emerson experts in the Biophorum Operations Group in several posts . Its mission: …is to create environments where the global biopharmaceutical industry can collaborate and accelerate its rate of progress, for the benefit of all. Emerson’s Sean Buckley alerted me to three recently published documents that he helped develop. These documents include: MES of the Future Manifesto CGT…
- 27 May 2022
BioPhorum MES of the Future

Jim Cahill

We’ve highlighted the work of Emerson experts in the Biophorum Operations Group in several posts . Its mission: …is to create environments where the global biopharmaceutical industry can collaborate and accelerate its rate of progress, for the benefit of all. Emerson’s Sean Buckley alerted me to three recently published documents that he helped develop. These documents include: MES of the Future Manifesto CGT…
- 27 May 2022
Hygienic Pressure Measurement for Pharmaceutical and Bioprocess Applications

Jim Cahill

The tolerance for pharmaceutical and bioprocess manufacturing variations is relatively small to meet the quality requirements of finished medicines and therapeutics. In a Process Instrumentation article, How to ensure reliable pressure transmitter measurement in pharmaceutical applications , Emerson’s Brandon Haschke shares how “Advanced hygienic pressure transmitters can reduce downtime and operating costs thanks to…
- 13 May 2022
Hygienic Pressure Measurement for Pharmaceutical and Bioprocess Applications

Jim Cahill

The tolerance for pharmaceutical and bioprocess manufacturing variations is relatively small to meet the quality requirements of finished medicines and therapeutics. In a Process Instrumentation article, How to ensure reliable pressure transmitter measurement in pharmaceutical applications , Emerson’s Brandon Haschke shares how “Advanced hygienic pressure transmitters can reduce downtime and operating costs thanks to…
- 13 May 2022
Overcoming Pharmaceutical and Biotech Manufacturing Challenges

Jim Cahill

Recently, the Pharma Manufacturing World Summit was held in Boston. The focus of the conference is to improve: … cost performance while maintaining quality and compliance in the midst of rapidly changing supply chain models among internal and external manufacturing… Emerson’s Christian Berg presented Are We There Yet? Tackling Manufacturing Challenges with the Digital Plant. Christian opened with the idea that tackling…
- 21 Apr 2022
Overcoming Pharmaceutical and Biotech Manufacturing Challenges

Jim Cahill

Recently, the Pharma Manufacturing World Summit was held in Boston. The focus of the conference is to improve: … cost performance while maintaining quality and compliance in the midst of rapidly changing supply chain models among internal and external manufacturing… Emerson’s Christian Berg presented Are We There Yet? Tackling Manufacturing Challenges with the Digital Plant. Christian opened with the idea that tackling…
- 21 Apr 2022
Faster Tech Transfer Unlocks Speed to Market

Jim Cahill

The rapid development of the COVID-19 vaccine has created a dramatic shift in the way the public and life sciences organizations view the manufacturing of pharmaceuticals. In a recent Q&A with Pharma Manufacturing , Nathan Pettus , president of Emerson’s process systems and solutions business, shared how a move toward more flexibility and modularity in the industry is cutting tech transfer times to drive improved speed…
- 12 Apr 2022
Faster Tech Transfer Unlocks Speed to Market

Jim Cahill

The rapid development of the COVID-19 vaccine has created a dramatic shift in the way the public and life sciences organizations view the manufacturing of pharmaceuticals. In a recent Q&A with Pharma Manufacturing , Nathan Pettus , president of Emerson’s process systems and solutions business, shared how a move toward more flexibility and modularity in the industry is cutting tech transfer times to drive improved speed…
- 12 Apr 2022
Adaptable Landscape Components Facilitate Digital Transformation

Jim Cahill

The BioPhorum Operations Group (BPOG) established a digital plant maturity model (DPMM) for biopharmaceutical manufacturing to define stages of factory evolution “from simple paper-based plants through to the fully automated and integrated ‘adaptive plant’ of the future.” The model gives organizations a common tool for industry comparison and measurement of progress. It also provides a platform to facilitate collaboration…
- 21 Mar 2022
Remote Monitoring Lays the Foundation for Lights-Out Manufacturing

Jim Cahill

It isn’t news that the global pandemic upended the way we operate our plants. When social distancing trapped our most valuable personnel outside the facilities we rely on, it suddenly meant finding new ways to get critical work done. But the reality is, those changes would have been coming—albeit less quickly—even without the influence of COVID. Retirements and shortages of experienced workers have been thinning out…
- 4 Mar 2022
Remote Monitoring Lays the Foundation for Lights-Out Manufacturing

Jim Cahill

It isn’t news that the global pandemic upended the way we operate our plants. When social distancing trapped our most valuable personnel outside the facilities we rely on, it suddenly meant finding new ways to get critical work done. But the reality is, those changes would have been coming—albeit less quickly—even without the influence of COVID. Retirements and shortages of experienced workers have been thinning out…
- 4 Mar 2022
Improve Speed to Market with Closed-Loop Process Control using Spectral PAT

Jim Cahill

We have witnessed an incredible change the last few years in how life sciences manufacturers deliver treatments . Today’s focus is on fast results, and that means products patients rely on cannot sit on shelves for weeks or months waiting on quality validation. In a recent article in Pharmaceutical Processing World , Emerson’s Bob Lenich and Bruce Greenwald explored a strategy plants are using to digitally transform…
- 3 Feb 2022
Improve Speed to Market with Closed-Loop Process Control using Spectral PAT

Jim Cahill

We have witnessed an incredible change the last few years in how life sciences manufacturers deliver treatments . Today’s focus is on fast results, and that means products patients rely on cannot sit on shelves for weeks or months waiting on quality validation. In a recent article in Pharmaceutical Processing World , Emerson’s Bob Lenich and Bruce Greenwald explored a strategy plants are using to digitally transform…
- 3 Feb 2022
Ultrasonic Welding Helps Ramp Up COVID Test Production

Jim Cahill

Demand for COVID test kits remain high and challenge manufacturers to maximize their production levels. In a Plastic News article (registration required), Automation suppliers help meet demand for COVID-19 testing kits , Emerson’s Vernon Murray , president of Branson assembly and welding technologies, highlighted the importance of welding technology in driving production efficiency. The article opens noting the production…
- 27 Jan 2022
Regulatory Requirements for Medical Devices Webinar

Jim Cahill

There is a new requirement for medical device companies selling into the European market, called the Medical Device Regulation, or MDR. This new regulation places a focus on the supply chain, meaning suppliers in the industry must have a good understanding of the new regulation in order to do business. Problems arise when the supplier fails to take the necessary steps to understand and implement MDR requirements. In this…
- 26 Jan 2022
Regulatory Requirements for Medical Devices Webinar

Jim Cahill

There is a new requirement for medical device companies selling into the European market, called the Medical Device Regulation, or MDR. This new regulation places a focus on the supply chain, meaning suppliers in the industry must have a good understanding of the new regulation in order to do business. Problems arise when the supplier fails to take the necessary steps to understand and implement MDR requirements. …
- 26 Jan 2022
Increasing Life Sciences Manufacturing Capacity

Jim Cahill

Supply chain disruptions have forced manufacturers and producers across the globe to reexamine how they source raw materials, inventory, produce, and disseminate what they produce. In an Australasian BioTechnology article, Facilities for a Strong Future , Emerson’s Michalle Adkins and Makarand Mujumdar share how pharmaceutical and biotech manufacturers can improve local capacity to meet the needs of the regions in which…
- 1 Dec 2021
Four Pillars for Life Sciences Line and Facility Efficiency

Jim Cahill

The overall Line and Facility effectiveness is becoming an increasing area of focus for Life Sciences manufacturers, where they are continually striving to gain the most from all of the available assets and materials. Challenges such as resource bottlenecks, impacts of variability, lack of visibility to production floor schedule changes, and off-line testing limit line and facility efficiencies are all factors that can…
- 22 Nov 2021
Improving Equipment Reliability for Life Sciences Manufacturers

Jim Cahill

Reliability of assets used in the manufacturing process is paramount for safe, efficient and effective operations. Unplanned asset failures, improper asset performance, poor maintenance planning, and untimely follow-through can cause shutdowns, under-utilized production equipment, deviations, or material/product losses. I caught up with Emerson’s Ben Arriola on how this applies to operational integrity for pharmaceutical…
- 9 Nov 2021
Holistic Production Readiness Strategy is Key to Operational Success

Jim Cahill

Initiating Good Manufacturing Practices (GMP) production operations, whether as part of facility start-up, product changeover, or following a shutdown, requires complex coordination of both logical and physical process controls. Inefficient configuration and qualification practices for automation and information management systems can lead to both start-up delays and productivity losses. A few items among the many to…
- 12 Oct 2021
Single-use pH Sensors in Biopharmaceutical Applications

Jim Cahill

As medicines and therapies become more specialized and targeted, the need for single-use measurement technology grows for biopharmaceutical manufacturers. Emerson’s Ben Arriola along with Jinbo Hu teamed up to share more about this trend in a BioProcess International special report, Design and Performance of a New Single-Use pH Sensor with Long Shelf Life and High Stability . In Ben’s article, Introducing the Next-Generation…
- 4 Oct 2021
Single-use pH Sensors in Biopharmaceutical Applications

Jim Cahill

As medicines and therapies become more specialized and targeted, the need for single-use measurement technology grows for biopharmaceutical manufacturers. Emerson’s Ben Arriola along with Jinbo Hu teamed up to share more about this trend in a BioProcess International special report, Design and Performance of a New Single-Use pH Sensor with Long Shelf Life and High Stability . In Ben’s article, Introducing the Next-Generation…
- 4 Oct 2021
A More Measured Move to the Pharma Cloud

Jim Cahill

There is little doubt that the recent explosion in available cloud technologies has been a boon for manufacturing across a wide array of industries. Pharmaceutical manufacturers are no exception, and organizations are now carefully considering where leveraging cloud technology makes the most sense to improve business and operational success. In his recent article, “Slow Rush to the Cloud” in Pharma Manufacturing, Emerson…
- 30 Sep 2021
Real-time Scheduling and Capacity Analysis Address Manufacturing Challenges

Jim Cahill

A friend of mine who works in Life Science manufacturing told me about a cynical wager she and her colleagues made after their 6-person team completed a 5-day marathon production planning and scheduling session. The 6-person cross functional team did everything in good old Excel. “How soon will they have to meet again to re-schedule and rework this excel file?” That happened about 16 months back – in the dark, early…
- 27 Sep 2021
Effective Personnel Drive Operational Integrity

Jim Cahill

As consumers of medicinal products of various kinds (vaccines, immunotherapies, tablets, capsules, cell therapies, etc.), we know that although product quality is important, reliable supply is also critical. A reliable supplier of therapeutic goods requires the facilities within its manufacturing supply chain to also be reliable suppliers of their intermediates and products. An important part of being a reliable supplier…
- 20 Sep 2021